Results 281 to 290 of about 1,482,586 (339)

Epidemiology of Cancer‐Associated Venous Thromboembolism Across the United States

American Journal of Hematology, EarlyView.
ABSTRACT Prior epidemiological studies on cancer‐associated venous thromboembolism (VTE) were limited by homogenous patient populations. We leverage Cosmos, a collaborative dataset of Epic electronic health record systems, to conduct an updated evaluation of cancer‐associated VTE in the United States (US).
Barbara D. Lam, Justine Ryu, Omid Jafari, Rock Bum Kim, Shengling Ma, Mrinal Ranjan, Jun Y. Jiang, Ang Li   +7 more
wiley   +1 more source

Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer. [PDF]

J Immunother Cancer
Jarrard D, Eickhoff J, Kyriakopoulos CE, Jeon D, Tonelli TP, Johnson L, Huang W, McNeel DG.   +7 more
europepmc   +1 more source

Multilevel associations between prostate cancer testing and socioeconomic position: a population-based register study from Stockholm, Sweden. [PDF]

BMJ Public Health
Rai B, Rado M, Oberg AS, Kuja-Halkola R, Clements MS.   +4 more
europepmc   +1 more source

Metastatic castrate-resistant prostate cancer to the penis resulting in malignant priapism and urethral obstruction. [PDF]

Urol Case Rep
Stewart C, Leong JY, Kelly WK, Shah MS.
europepmc   +1 more source

Context-dependent cytotoxicity and ADMET profiling of methoxylated flavonoids as novel leads for metastatic prostate cancer. [PDF]

RSC Adv
Hourani W.
europepmc   +1 more source

Editorial Comment on Beyond Total PSA: Clinical Significance of S2,3PSA% in Reducing Unnecessary Prostate Biopsies. [PDF]

Int J Urol
Goto Y.
europepmc   +1 more source

Prostate Cancer

Oncology Times, 2004
openaire   +2 more sources

Sodium-Glucose Cotransporter 2 Inhibitors for Patients With Prostate Cancer Undergoing Hormone Therapy.

JAMA Oncol
Shi R, Zhan Y, Ma R, Ali S, Yao C, Chun TTS, Ng AT, Chiu MK, Li BCW, Na R.   +9 more
europepmc   +1 more source